Beacon Biosignals was built on a shared mission: to unlock the power of brain data to transform how we diagnose, treat, and understand neurological and psychiatric conditions.
Beacon’s AI-powered technology is using precision neuroscience to accelerate drug development and power the next generation of home sleep testing diagnostics, so life-changing treatments can reach the right patients faster.
The company combines advanced AI-driven technology with deep biopharma domain knowledge to accelerate neuroscience innovation across clinical trial design, biomarker discovery, and at-home diagnostics. It is building the world's largest clinically validated neurophysiology dataset to enable more targeted, personalized therapies.